Moreld,
I read somewhere that Biota will be getting their share of royalties from the Japanese made LANI; Sankyo will be getting their royalties and the profit from making and selling the stuff. Outside Japan the same applies with regards royalties for both parties.
It's a pity Biota doesn't have any manufacturing ambitions, in particular with regards to the HRV antiviral since there is no partner yet and treating the common cold could be big.
I suppose if Biota made too much money they'd have to pay dividends, a skill which board members have shown no aptitude for until now.
- Forums
- ASX - By Stock
- BTA
- can someone point out where i am wrong?
can someone point out where i am wrong?, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online